http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104415026-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_356bf4c635b07df27f3535c2f6de0f2d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 2013-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ff3e8d2f3bf7fd2fa0495ec6987e84d |
| publicationDate | 2015-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104415026-A |
| titleOfInvention | Application of deuterated fumaric acid-enriched derivative in treatment of multiple sclerosis |
| abstract | The invention relates to application of a deuterated fumaric acid-enriched derivative in preparation of medicaments for treating or preventing multiple sclerosis. The deuterated fumaric acid-enriched derivative is selected from the following components: 2,3-dideuterium- or 2-deuterium- or 3-deuterium-dialkyl fumarate, 2,3-dideuterium- or 2-deuterium- or 3-deuterium-hyrogen monoalkyl fumarate, 2,3-dideuterium- or 2-deuterium- or 3-deuterium-salt monoalkyl fumarate, 2,3-dideuterium- or 2-deuterium- or 3-deuterium-monoamide fumarate, 2,3-dideuterium- or 2-deuterium- or 3-deuterium-salt monoamide fumarate, 2,3-dideuterium- or 2-deuterium- or 3-deuterium-diamide fumarate and 2,3-dideuterium- or 2-deuterium- or 3-deuterium-monoalkyl monoamide fumarate as well as the mixture of the compounds. The application is found based on the fact that cellular pathways of Nrf2 in cells can be activated by the deuterated fumaric acid derivative. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023045377-A1 |
| priorityDate | 2013-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.